Literature DB >> 22898056

Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.

Zhanyong Bing1, Priti Lal, Song Lu, Amy Ziober, John E Tomaszewski.   

Abstract

Kidney tumors of various types may behave differently and have different prognosis. Because of some overlapping morphological features and immunohistochemical staining pattern, they may pose diagnostic challenge. Therefore, it is necessary to explore additional immunohistochemical stains to help classifying these epithelial neoplasms. Tissue microarrays of 20 cases each of renal cell carcinomas of clear cell, chromophobe, and papillary variants and oncocytoma were constructed and used to test a panel of immunohistochemical markers including carbonic anhydrase IX, galectin-3, cytokeratin 7 (CK7), and α-methylacyl coenzyme a racemase. Carbonic anhydrase IX was highly sensitive for clear cell renal cell carcinoma (90% positivity) and was negative in all other renal epithelial tumors except for 1 chromophobe renal cell carcinoma (chRCC). Expression of galectin-3 was found mostly in renal tumors with oncocytic features, including oncocytomas (100%) and chRCCs (89%). α-Methylacyl coenzyme a racemase was positive in papillary renal cell carcinoma (100%). CK7 was positive in papillary renal cell carcinoma (90%), chRCC (89%), and oncocytoma (90%). Although both chRCC and oncocytoma were positive for CK7, but with a different patterns, CK7 staining in chRCC was diffuse, whereas it was sporadic in oncocytoma. Panel of carbonic anhydrase IX, galectin-3, CK7, and α-methylacyl coenzyme a racemase is sensitive and specific for the differential diagnosis of the renal epithelial tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898056     DOI: 10.1016/j.anndiagpath.2012.07.002

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  10 in total

1.  Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.

Authors:  Hanan AlSaeid Alshenawy
Journal:  Pathol Oncol Res       Date:  2015-02-25       Impact factor: 3.201

2.  Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome sequencing study.

Authors:  Yuan Ren; Kunpeng Liu; Xueling Kang; Lijuan Pang; Yan Qi; Zhenyan Hu; Wei Jia; Haijun Zhang; Li Li; Jianming Hu; Weihua Liang; Jin Zhao; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

3.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

4.  Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  Keng Lim Ng; Robert J Ellis; Hemamali Samaratunga; Christudas Morais; Glenda C Gobe; Simon T Wood
Journal:  Transl Androl Urol       Date:  2019-05

Review 5.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

6.  MicroRNAs as Urinary Biomarker for Oncocytoma.

Authors:  Melanie von Brandenstein; Monika Schlosser; Jan Herden; Axel Heidenreich; Stefan Störkel; Jochen W U Fries
Journal:  Dis Markers       Date:  2018-07-16       Impact factor: 3.464

7.  Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma.

Authors:  Adam Kowalewski; Łukasz Szylberg; Janusz Tyloch; Paulina Antosik; Izabela Neska-Długosz; Łukasz Frąckowski; Dominik Tyloch; Piotr Purpurowicz; Dariusz Grzanka
Journal:  Pathol Oncol Res       Date:  2018-11-22       Impact factor: 3.201

8.  Comparative Analysis for the Distinction of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma in Computed Tomography Imaging Using Machine Learning Radiomics Analysis.

Authors:  Abeer J Alhussaini; J Douglas Steele; Ghulam Nabi
Journal:  Cancers (Basel)       Date:  2022-07-25       Impact factor: 6.575

9.  Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features.

Authors:  Hanan AlSaeid Alshenawy
Journal:  J Microsc Ultrastruct       Date:  2015-02-03

Review 10.  Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management.

Authors:  Jean Courcier; Alexandre de la Taille; Maya Nourieh; Ingrid Leguerney; Nathalie Lassau; Alexandre Ingels
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.